Skip to content

Medline, Inc. MDLN Book value per share

Book value per share at other companies

Cardinal Health logo
Cardinal HealthCAH
-$12.00+1.9%
McKesson logo
McKessonMCK
-$17.50-8.1%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$41.30+12.4%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$23.34+16.6%
Abbott logo
AbbottABT
$29.80+6.7%
Medtronic logo
MedtronicMDT
$38.40+3.1%

Other financials

Income statement

See full
Revenue$7.4B+10.7%
Gross profit$1.8B+0.9%
Operating income$422.0M-26.1%
Net income$239.0M-25.1%
EPS (diluted)$0.16

Balance sheet

See full
Cash & equivalents$2.2B+166%
Total debt$12.6B
Total equity$11.3B
Total assets$39.0B

Cash flow

See full
Operating cash flow$412.0M-39.6%
CapEx$96.0M-2.0%
Free cash flow$316.0M-45.9%

Valuation

See full
Market cap$30.8B
Enterprise value$41.12B
P/E36.6×
P/S1.2×

Profitability

See full
Gross margin27.4%+1.5pp
Operating margin8.5%+2.3pp
Net margin4.6%+2.7pp

Returns & leverage

See full
Return on equity7.7%
Debt / equity1.1×
Current ratio4.4×

Where this comes from

Calculated from Medline, Inc. ’s reported figures.

Based on the most recent quarter.

The official record: Medline, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medline, Inc. 's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medline, Inc. 's book value per share?
Medline, Inc. (MDLN) reported book value per share of $13.67 in Q1 2026.
What does book value per share mean?
The accounting net worth of the company behind each share.
How do you interpret book value per share?
A steadily rising book value per share reflects retained earnings compounding into equity. Compare against the share price (price-to-book) to gauge how the market values that book equity.
How does book value per share compare across companies?
Most meaningful for asset- and equity-heavy businesses (financials, industrials); less informative for asset-light firms whose value is intangible.